Seller record · rxspanmd.com

RxSpan MD

Recorded September 2026 · Standard v1.1

Fails 1 of 8 criteria. S5, analytical documentation: No certificate, lot number or purity figure appears. Nine testing terms returned zero across the 33 captures covering the public pages, the medication pages and the rendered intake.

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, three brand GLP-1 drugs, and a longevity line running sermorelin, glutathione, GHK-Cu and PT-141. Its product interface holds 133 records and 33 of them render on a public page.

Operating entity RxSpan MD LLC

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	rxspanmd.com
S2	Prescription gating	PASS	intake.rxspanmd.com
S3	Pharmacy identification	PASS	rxspanmd.com
S4	Compounding disclosure	PASS	rxspanmd.com/medications/semaglutide
S5	Analytical documentation	FAIL	rxspanmd.com
S6	Business address	PASS	rxspanmd.com/legal/terms-of-service
S7	Price disclosure	PASS	rxspanmd.com/category/weight-loss
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSA licensed United States physician is stated to review every case and approve every plan, and the terms repeat it. A category page adds separately that the review happens after checkout and that a prescription is not guaranteed.Source: rxspanmd.com.

S2PASSMedical questions arrive before payment. The four-step intake reaches a diabetes question at step two with no card or billing field before it, and the site states elsewhere that the clinical review itself follows checkout.Source: intake.rxspanmd.com.

S3PASSFour filling pharmacies are named with telephone numbers and web addresses: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx. They sit inside a questions control that is closed on load, and no street address is printed for any of the four.Source: rxspanmd.com.

S4PASSThe semaglutide and tirzepatide pages state that compounded products are not FDA-approved and that the agency does not review them for safety, effectiveness or quality. A comparison page labels every row compounded or brand.Source: rxspanmd.com/medications/semaglutide.

S5FAILNo certificate, lot number or purity figure appears. Nine testing terms returned zero across the 33 captures covering the public pages, the medication pages and the rendered intake.Source: rxspanmd.com.

S6PASSAll four legal pages print a penthouse suite address on North Roxbury Drive in Beverly Hills, California, under the operating company name.Source: rxspanmd.com/legal/terms-of-service.

S7PASSEvery rung is printed on public category pages before intake. Semaglutide injection runs 249 dollars a month, or 175 dollars a month stated as one upfront payment of 2,094 dollars across twelve months, and three brand GLP-1 drugs are priced from 1,069 to 1,349 dollars for a first month.Source: rxspanmd.com/category/weight-loss.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection and capsules, compounded tirzepatide injection and capsules, Ozempic, Wegovy, Zepbound, sermorelin oral tablet, glutathione, GHK-Cu, PT-141 injection, NAD+ injection, nasal spray and tablet, hair loss and sexual health medications.

Unpaid link. RxSpan MD does not pay the site, and nothing is earned when it is used. Funding.

Visit RxSpan MD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.